News

GSK climbs after winning FDA priority review for oral gonorrhoea antibiotic

GSK (NYSE:GSK) (LON:GSK) said on Monday that the U.S. Food and Drug Administration has accepted its priority review ...

CureVac Resolves Patent Litigation with Pfizer/BioNTech

CureVac ( (CVAC)) has provided an announcement. On August 7, 2025, CureVac announced the resolution of U.S. patent litigation with Pfizer/BioNTech concerning mRNA-based COVID-19 vaccines. As part of ...
pharmaphorum7h

Vinay Prasad returns to FDA

The word from the FDA is that Prasad has come back at the request of the regulator's Commissioner, Marty Makary, who ...
InvestorsHub on MSN5h

GSK shares rise after FDA grants priority review for oral gonorrhea antibiotic

GSK (NYSE:GSK) announced Monday that the U.S. Food and Drug Administration has accepted its priority review application for ...
Pharmaceutical Commerce3h

Pharma Pulse: FDA Launches Pre-Check Program, GSK Secures mRNA Settlement, and Pharma Leaders Eye US Investment Boost

This episode of Pharma Pulse explores the FDA’s new proactive quality review initiative for drug manufacturing, GSK’s $370 ...

GSK bid to expand Blujepa label for gonorrhea granted FDA priority review

GSK (NYSE:GSK) announced on Monday that the U.S. FDA has granted priority review for its marketing application, aimed at ...